Hellenic Healthcare



Project number:


Business sector:

Manufacturing and Services

Notice type:


Environmental category:


Approval date:

04 Jul 2018



PSD disclosed:

31 May 2018

Translated version of this PSD: Greek

Project Description

Long-term senior loan of up to EUR 32 million to Perseus Healthcare S.A., a public limited company domiciled in Greece, operating under the business name Metropolitan Hospital (Athens), to finance the capital expenditure programme and working capital, as well as to partly refinance its existing debt portfolio.

Project Objectives

Support the investment programme carried out by Metropolitan hospital at its premises in Athens. The proceeds from the EBRD loan will be allocated towards capex consisting of reconstruction of buildings and purchase of new medical equipment, with the aim to increase capacity and improve quality of its healthcare services.

Transition Impact

The transition impact of the proposed project will be derived from:

  • Efficiency gains and cost savings enabling the improvements in company's operational performance.
  • Financial restructuring.

Client Information


Perseus Healthcare S.A., a public limited company domiciled in Greece, operating under the business name Metropolitan Hospital (Athens).

EBRD Finance Summary

EUR 32,000,000.00

Senior secured loan to the borrower in the amount of up to EUR 32 million.

Total Project Cost

EUR 32,000,000.00

Environmental and Social Summary

Categorised B (2014 ESP). Financing capex investments at the existing hospital (262 beds) in Athens is associated with specific environmental and social issues which can be addressed via the implementation of appropriate mitigation measures. Environmental and Social Due Diligence (ESDD) for the project was carried out by ESD staff and comprised a review of the completed E&S Questionnaire; discussions with the client management; and a visit to the hospital. The proposed capex programme will not increase hospital bed numbers but will carry out refurbishment of the basement, ground floor and facade, as well as installation of new medical equipment. The hospital has adequate environmental, health and safety, infection control and HR management procedures in place in accordance with applicable Greek law. Both the hospital's current operations and the project are not associated with significant environmental and social issues. An E&S Action Plan (ESAP) has been developed to address continuous implementation of all relevant procedures and antibiotic stewardship to address Antimicrobial Resistance (AMR) issues in the hospital. The hospital is required to ensure that the project adheres to EBRD PRs and IFC Environmental, Health and Safety Guideline for Healthcare Facilities.

The hospital is accredited with Temos-Excellence in Medical Tourism & Temos Quality in International Patient Care, which certifies the quality of medical service accreditation for international patients and medical travellers and is based on "Quality Made in Germany"; the hospital having a Certified European Stroke Organisation (ESO) Stroke Unit; ISO 15189-2012 (laboratory certification) for more than 40 type of blood testing procedures; ISO 22000 (Food Safety); ISO9001 (Quality Management); and a Certificate of Membership for 2017 from Breast Centre Network. To keep these accreditations, five different external audits take place every year. An internal quality management audit is carried out by the Quality Department once a month. The hospital has infectious control, hazardous substance and radioactive substance management systems, occupational health & safety, medical waste management and life and fire safety procures in place. A licensed company comes to collect medical waste and dispose of it in a medical waste incinerator every day. The hospital's HR policy, including an employee grievance mechanism, is in line with PR2. Patient rights are respected in accordance with national law and a patient grievance mechanism is in place. Statistics show that Greece has a high use of antibiotics and has a correspondingly high rate of AMR occurrence in EU member countries. The Greek government has developed an AMR National Action Plan to address it. The hospital reports its AMR surveillance data to the Hellenic Centre for Disease Control & Prevention (HCDCP), the national AMR surveillance network centre. Under the project, the hospital continues to address in-hospital AMR issues by antibiotics stewardship and improved diagnostic.

Technical Cooperation


Company Contact Information

Ms Aggeliki Siolavou
+30 210 4809188
Ethnarchou Makariou 9, Pireas 185 47, Greece

Business opportunities

For business opportunities or procurement, contact the client company.

For state-sector projects, visit EBRD Procurement: Tel: +44 20 7338 6794
Email: procurement@ebrd.com

General enquiries

EBRD project enquiries not related to procurement:
Tel: +44 20 7338 7168
Email: projectenquiries@ebrd.com

Public Information Policy (PIP)

The PIP sets out how the EBRD discloses information and consults with its stakeholders so as to promote better awareness and understanding of its strategies, policies and operations. Please visit the Public Information Policy page below to find out how to request a Public Sector Board Report.
Text of the PIP

Share this page: